Search
for

    Sort by

    Research 31–60 of 1000+

    1. Serum level of retinol-binding protein 4 in alopecia areata: relation with recurrence and severity 2022
    2. Association Between Oxidative Stress Biomarkers And Clinical Severity Of Alopecia Areata: A Systematic Review Adolescencia e Saude · 2026
    3. Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2 Dermatology and Therapy · 2023 · 1 citations
    4. Cellular retinol‐binding protein‐1 expression increases with increasing clinical severity of alopecia areata Journal of cosmetic dermatology · 2018 · 2 citations
    5. Serum Epidermal Growth Factor Level and its Relation to Severity of Alopecia Areata International Journal of Applied Biochemistry and Molecular Biology. · 2024 · 1 citations
    6. Demographic Features, Clinical Factors and Severity of Disease among Patients with Alopecia Areata Egyptian Reviews for Medical and Health Sciences . · 2025
    7. Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata The Egyptian Journal of Hospital Medicine · 2022
    8. Serum 25-Hydroxy Vitamin D Level in Patients with Alopecia Areata and Its Relationship with Severity of the Disease Journal of Dhaka Medical College · 2025
    9. Evaluation of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, CRP and ESR with disease severity in patients with alopecia areata International Journal of Dermatology Research · 2025
    10. Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study Journal of the American Academy of Dermatology · 2024 · 4 citations
    11. BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience British Journal of Dermatology · 2023
    12. Alopecia areata: A review Journal of the Saudi Society of Dermatology & Dermatologic Surgery · 2013 · 29 citations
    13. Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)* 2021 · 14 citations
    14. 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1) Journal of Investigative Dermatology · 2019 · 5 citations
    15. Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis Journal of Cosmetic Dermatology · 2020 · 1 citations
    16. Gene Expression of Osteopontin in Alopecia Areata? A Case-Controlled Study Skin Pharmacology and Physiology · 2014 · 1 citations
    17. Tofacitinib in the Recalcitrant Cases of Alopecia Areata: A Pilot Study International Journal of Science and Research (IJSR) · 2025
    18. Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2025
    19. Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2024
    20. Treatment of Alopecia Areata using Transdermal Delivery of 5-Fluorouracil by Fractional CO2 Laser versus Intralesional Injection of 5-Fluorouracil Zagazig University Medical Journal · 2024
    21. Does zinc have a role in alopecia areata? A clinic-biochemical study Global journal of health sciences and research · 2023
    22. Alopesia universalis pada anak yang berespon baik dengan terapi kombinasi: sebuah laporan kasus Intisasi sains media · 2022
    23. Reply to “Vitamin D status in scarring and nonscarring alopecia” Journal of the American Academy of Dermatology · 2022
    24. Successful Treatment of Alopecia Totalis with Topical Calcipotriol: Serial Case Report and Review of the Literature 2020
    25. Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata Indian Journal of Dermatology · 2019 · 10 citations
    26. Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population International Journal of Dermatology · 2021 · 9 citations
    27. Comparative study of efficacy of topical mometasone with calcipotriol versus mometasone alone in the treatment of alopecia areata International Journal of Trichology · 2019 · 9 citations
    28. Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm Clinical Pharmacokinetics · 2024 · 5 citations
    29. Study on Serum Vitamin D in Alopecia Areata Patients Journal of Nepal Health Research Council · 2019 · 5 citations
    30. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review. PubMed · 2018 · 5 citations